Dexmedetomidine-remifentanil or propofol-remifentanil anesthesia in patients undergoing intracranial surgery

Neurosurgery Quarterly

Volumn 15, Issue 2, 2005, Pages 122-126

  Günes, Yasemin ^a   Gündüz, Murat ^a   Özcengiz, Dilek ^a   Özbek, Hayri ^a   Isik, Geylan ^a  

^a CUKUROVA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Dexmedetomidine; Intracranial surgery; Propofol; Remifentanil

Indexed keywords

DEXMEDETOMIDINE; PROPOFOL; REMIFENTANIL;

ADULT; AGED; ANESTHESIA INDUCTION; ANESTHETIC RECOVERY; ARTICLE; BRAIN SURGERY; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; EXTUBATION; FEMALE; GENERAL ANESTHESIA; GLASGOW COMA SCALE; HEMODYNAMICS; HUMAN; INFORMED CONSENT; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PERIOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SKIN INCISION; SYSTOLIC BLOOD PRESSURE; WAKEFULNESS;

EID: 18844424038     PISSN: 10506438     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.wnq.0000163345.17549.07     Document Type: Article

References (25)

1. Egan TD, Lemmens HJM, Fiset P. The pharmacokinetics of the new short acting opioid remifentanil (GI87084B) in healthy adult male volunteers. Anesthesiology. 1993;79:881-892.
2. Egan TD. Pharmacokinetics and pharmacodynamics of remifentanil: an update in the year 2000. Curr Opin Anesthesiol. 2000;13:449-455.
3. Gerlach K, Uhlig T, Huppe M, et al. Remifentanil-propofol versus sufentanil-propofol anaesthesia for supratentorial craniotomy: a randomized trial. Eur J Anaesthesiol. 2003;20:813-820.
4. Ravussin P, Revelly JP, Chiolero R. Clinical use of propofol in neuroanesthesia. Agressologie. 1991;32:407-411.
5. Stephan H, Sonntag H, Schenk HD, et al. Effect of Disoprivan (propofol) on the circulation and oxygen consumption of the brain and CO2 reactivity of brain vessels in the human. Anaesthesist. 1987;36:60-65.
6. Ishiyama T, Dohi S, Iida H, et al. Mechanisms of dexmedetomidine-induced cerebrovascular effects in canine in vivo experiments. Anesth Analg. 1995;81:1208-1215.
7. Ganjoo P, Farber NE, Hudetz A, et al. In vivo effects of dexmedetomidine on laser-Doppler flow and pial arteriolar diameter. Anesthesiology. 1998;88:429-439.
8. Zornow MH, Fleischer JE, Scheller MS, et al. Dexmedetomidine, an α2-adrenergic agonist, decreases cerebral blood flow in the isoflurane-anesthetized dog. Anesth Analg. 1990;70:624-630.
9. Asano Y, Koehler RC, Kawaguchi T, et al. Pial arteriolar constriction to alpha-2 adrenergic agonist dexmedetomidine in the rat. Am J Physiol. 1997;272:H2547-H2556.
10. Ohata H, Iida H, Dohi S, et al. Intravenous dexmedetomidine inhibits cerebrovascular dilation induced by isoflurane and sevoflurane in dogs. Anesth Analg. 1999;89:370-377.
11. Lawrence CJ, De Lange S. Effects of a single pre-operative dexmedetomidine dose on isoflurane requirements and peri-operative haemodynamic stability. Anaesthesia. 1997;52:736-744.
12. Aho M, Lehtinen AM, Erkola O, et al. The effect of intravenously administered dexmedetomidine on perioperative hemodynamics and isoflurane requirements in patients undergoing abdominal hysterectomy. Anesthesiology. 1991;74:997-1002.
13. Scheinin B, Lindgren L, Randell T, et al. Dexmedetomidine attenuates sympathoadrenal responses to tracheal intubation and reduces the need for thiopentone and perioperative fentanyl. Br J Anaesth. 1992;68:126-131.
14. Aantaa R, Jaakola ML, Kallio A, et al. Reduction of the minimum alveolar concentration of isoflurane by dexmedetomidine. Anesthesiology. 1997;86:1055-1060.
15. Sturaitis MK, Kroin JS, Swamidoss CP, et al. Effects of intraoperative dexmedetomidine infusion on hemodynamic stability during brain tumor resection. ASA 2002. Abstract A310.
16. Werner C. [Effects of analgesia and sedation on cerebrovascular circulation, cerebral blood volume, cerebral metabolism and intracranial pressure.] Anaesthesist. 1995;44(Suppl 3):S566-S572.
17. Belleville JP, Ward DS, Bloor BC, et al. Effects of intravenous dexmedetomidine in humans. I. Sedation, ventilation, and metabolic rate. Anesthesiology. 1992;77:1125-1133.
18. Bol CJ, Vogelaar JP, Mandema JW. Anesthetic profile of dexmedetomidine identified by stimulus-response and continuous measurements in rats. J Pharmacol Exp Ther. 1999;291:153-160.
19. Dutta S, Karol MD, Cohen T, et al. Effect of dexmedetomidine on propofol requirements in healthy subjects. J Pharm Sci. 2001;90:172-181.
20. Horvath G, Szikszay M, Rubicsek G, et al. An isobolographic analysis of the hypnotic effects of combinations of dexmedetomidine with fentanyl or diazepam in rats. Life Sci. 1992;50:215-220.
21. Dawson C, Ma D, Chow A, et al. Dexmedetomidine enhances analgesic action of nitrous oxide. Mechanisms of Action Anesthesiology. 2004;100:894-904.
22. Jorden VS, Pousman RM, Sanford MM, et al. Dexmedetomidine overdose in the perioperative setting. Ann Pharmacother. 2004;38:803-807.
23. Ramsay MA, Luterman DL. Dexmedetomidine as a total intravenous anesthetic agent. Anesthesiology. 2004;101:787-790.
24. Arain SR, Ebert TJ. The efficacy, side effects and recovery characteristics of dexmedetomidine versus propofol when used for intraoperative sedation. Anesth Analg. 2002;95:461-466.
25. Guy J, Hindman BJ, Baker KZ, et al. Comparison of remifentanil and fentanyl in patients undergoing craniotomy for supratentorial space-occupying lesions. Anesthesiology. 1997;86:514-524.